ELS-tíðindi - nóvember 2000

76 ELS tíðindi 11/2000
(21) 5548
(22) 27.6.2000
(41) 27.6.2000
(51) C07D 249/06; A61K 31/475; A61K
31/495; A61K 31/41; A61K 31/415;
A61K 31/425; A61K 31/47; C07D
521/00; C07D 231/14; C07D 401/04;
C07D 403/04; C07D 417/04; C07D
405/04; C07D 413/04; C07D 409/04
(54) N - [(setinn fimm -atóma dí - eða
tríaza díómettað hring) karbónýl]
gúanidín afleiður til meðhöndlunar á
blóðþurrð.
(71) Pfizer Products Inc., Eastern Point
Road, Groton, Connecticut 06340,
Bandaríkjunum.
(72) Ernest S. Hamanaka; Angel
Guzman-Perez; Roger B. Ruggeri;
Ronald T. Wester; Christian J.
Mularski; Groton, Connecticut,
Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 27.2.98, US, 60/076,362
(85) 27.6.2000
(86) 5.2.99, PCT/IB99/00206
(21) 5561
(22) 14.7.2000
(41) 14.7.2000
(51) A61K 7/48
(54) Fegrunarsamsetning sem inniheldur
efnasamband með virkniörvandi
interleukíni-6.
(71) Sanofi-Synthelabo, 174, Avenue
de France, 75013 París, Frakklandi.
(72) Pierre Casellas, Montpellier; Jean-
Marie Derocq, Murviel les
Montpellier; Jean-Marie Pereillo,
Portet sur Garonne; Frakklandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 11.2.98, FR, 98/01637
(85) 14.7.2000
(86) 3.2.99, PCT/FR99/00220
(21) 5562
(22) 14.7.2000
(41) 14.7.2000
(51) C07C 231/00
(54) Nýjar díhýdroxýhexanósýru afleiður.
(71) Pfizer Products Inc., Eastern Point
Road, Groton, Connecticut 06340,
Bandaríkjunum.
(72) John Charles Kath, Waterford;
Matthew Frank Brown, Pawcatuck;
Christopher Stanley Poss,
North Stonington; Connecticut,
Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 5.2.98, US, 60/073,801
(85) 14.7.2000
(86) 18.1.99, PCT/IB99/00067
(21) 5563
(22) 17.7.2000
(41) 17.7.2000
(51) G06F
(54) Stækkanlegt samþættingarkerfi fyrir
dreifða framtaksnotkun.
(71) Saga Software, Inc., 11190 Sunrise
Valley Drive, Reston, Virginia 20191,
Bandaríkjunum.
(72) Hon-Siew Yee, Herndon; John Timothy
Taylor, Leesburg; Gary Alan Gordon,
McLean; Virginia, Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 18.11.98, US, 60/108,993
5.10.99, US, 09/4 12,595
5.10.99, US, 09/4 12,633
(85) 17.7.2000
(86) 18.11.99, PCT/US99/27238
(21) 5567
(22) 20.7.2000
(41) 20.7.2000
(51) C12N 15/60; C12N 15/52; C12N 9/88;
C12N 15/76; C12P 19/62; C12P 17/18;
C12Q 1/527; C12N 1/21
(54) Streptomyces avermitilis gen sem
stýrir hlutfallinu milli B2:B1
avermektína.
(71) Pfizer Products Inc., Eastern Point
Road, Groton, Connecticut 06340,
Bandaríkjunum.
(72) Kim Jonelle Stutzman-Engwall, East
Lyme, Connecticut, Bandaríkjunum;
Yoshihiro Katoh, Aichi-ken, Japan;
Hamish Alastair Irvine McArthur,
Gales Ferry, Connecticut,
Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 13.2.98, US, 60/074,636
(85) 20.7.2000
(86) 25.1.99, PCT/IB99/00130
(21) 5568
(22) 20.7.2000
(41) 20.7.2000
(51) A61K 31/535
(54) Lyfjafræðilega virkt morfólínól.
(71) Glaxo Group Limited, Glaxo
Wellcome House, Berkeley Avenue,
Greenford, Middlesex UB6 ONN,
Bretlandi.
(72) Phillip Frederick Morgan; David Lee
Musso; John Joseph Partridge;
Research Triangle Park, North Carolina,
Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 21.1.98, GB, 9801230.5
22.1.98, US, 60/072,180
(85) 20.7.2000
(86) 20.1.99, PCT/US99/01134
(21) 5569
(22) 20.7.2000
(41) 20.7.2000
(51) A61K 9/00; A61K 47/12; A61K 31/52
(54) Lyfjasamsetningar.
(71) Glaxo Group Limited, Glaxo
Wellcome House, Berkeley Avenue,
Greenford, Middlesex UB6 ONN,
Bretlandi.
(72) Nikki Thoennes Brooks, Glen Allen,
Virginia, Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 6.2.98, GB, 9802472.2
(85) 20.7.2000
(86) 4.2.99, PCT/EP99/00663
(21) 5571
(22) 24.7.2000
(41) 24.7.2000
(51) A61K 31/565; A61K 31/57
(54) Lyfjasamsetningar sem valvíst bæta
upp estrógenskort í miðtaugakerfinu.
(71) Jenapharm GmbH & Co. KG, Otto-
Schott-Strasse 15, D-07745 Jena,
Þýskalandi.
(72) Vladimir Patchev, Jena; Michael
Oettel, Jena; Ina Thieme,
Graitschen; Sigfrid Schwarz, Jena;
Wolfgang Römer, Jena; Þýskalandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 20.2.98, DE, 19807264.3
15.5.98, DE, 19821831.1
(85) 24.7.2000
(86) 10.2.99, PCT/DE99/00353
(21) 5575
(22) 25.7.2000
(41) 25.7.2000
(51) C07D 487/04; A61K 31/50
(54) Setið 1,2,4-tríasóló[3,4-a]pýridasín.
(71) Merck Sharp & Dohme Limited,
Hertford Road, Hoddesdon,
Hertfordshire EN11 9BU, Bretlandi.
(72) William Robert Carling; Tamara
Ladduwahetty; Angus Murray
Macleod; Kevin John Merchant;
Kevin William Moore; Francine
Sternfeld; Leslie Joseph Street;
Harlow, Essex, Bretlandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 25.2.98, GB, 9803992.8
6.5.98, GB, PCT/GB98/0130
12.11.98, GB, 9824896.6
(85) 25.7.2000
(86) 17.2.99, PCT/GB99/00485